Paper39604129
Effect of Transferrin-Modified Fe3O4 Nanoparticle Targeted Delivery miR-15a-5p Combined With Photothermal Therapy on Lung Cancer.
Lan X and 10 others. Thorac Cancer, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Effect of Transferrin-Modified Fe3O4 Nanoparticle Targeted Delivery miR-15a-5p Combined With Photothermal Therapy on Lung Cancer. Papers, record 39604129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39604129
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of Transferrin-Modified Fe3O4 Nanoparticle Targeted Delivery miR-15a-5p Combined With Photothermal Therapy on Lung Cancer.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Lung Neoplasms | Major topic |
| Photothermal Therapy | Major topic |
| Transferrin | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Cell Proliferation | |
| Apoptosis | |
| Xenograft Model Antitumor Assays |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ZR2023MH223 | The Shandong Science and Technology Committee | PubMed | ||
| ZR2020QH221 | The Shandong Science and Technology Committee | PubMed | ||
| ZR2022LSW002 | The Shandong Science and Technology Committee | PubMed | ||
| 82002604 | The National Natural Science Foundation of China | PubMed | ||
| 2021KJ101 | The Support Plan for Youth Entrepreneurship and Technology of Colleges and Universities in Shandong | PubMed | ||
| 2019KJK014 | The Support Plan for Youth Entrepreneurship and Technology of Colleges and Universities in Shandong | PubMed | ||
| ts201712067 | The Shandong Province Taishan Scholar Project | PubMed |
Source PubMed
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35079042 | Receptor-targeted nanoparticles modulate cannabinoid anticancer activity through delayed cell internalization. | Sci Rep | 2022 | https://conductscience.org/library/papers/35079042 | PubMed |
| 2 | 36677964 | Hydroponic Ginseng ROOT Mediated with CMC Polymer-Coated Zinc Oxide Nanoparticles for Cellular Apoptosis via Downregulation of BCL-2 Gene Expression in A549 Lung Cancer Cell Line. | Molecules | 2023 | https://conductscience.org/library/papers/36677964 | PubMed |
| 3 | 22510488 | The cytotoxicity of polycationic iron oxide nanoparticles: common endpoint assays and alternative approaches for improved understanding of cellular response mechanism. | J Nanobiotechnology | 2012 | https://conductscience.org/library/papers/22510488 | PubMed |
| 4 | 34785791 | MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis. | Leukemia | 2022 | https://conductscience.org/library/papers/34785791 | PubMed |
| 5 | 39114869 | Zinc Coordination Lipid Nanoparticles Co-Delivering Calcium Peroxide and Chelating STING agonist for Enhanced Cancer Metalloimmunotherapy. | Small | 2024 | https://conductscience.org/library/papers/39114869 | PubMed |
| 6 | 36603409 | Efficient improvement in chemo/photothermal synergistic therapy against lung cancer using Bi@Au nano-acanthospheres. | Colloids Surf B Biointerfaces | 2023 | https://conductscience.org/library/papers/36603409 | PubMed |
| 7 | 29274527 | Rattle-type Au@Cu2-xS hollow mesoporous nanocrystals with enhanced photothermal efficiency for intracellular oncogenic microRNA detection and chemo-photothermal therapy. | Biomaterials | 2018 | https://conductscience.org/library/papers/29274527 | PubMed |
| 8 | 29512452 | Formulations, Pharmacodynamic and Clinical Studies of Nanoparticles for Lung Cancer Therapy - An Overview. | Curr Drug Metab | 2018 | https://conductscience.org/library/papers/29512452 | PubMed |
| 9 | 37678122 | Highly effective synthesis of novel structured phospholipid emulsifiers using magnetically recyclable Fe3O4@SiO2/M (M = Zn or Al) composite. | Food Chem | 2024 | https://conductscience.org/library/papers/37678122 | PubMed |
| 10 | 38868823 | Targeted nanotherapy platform mediated tumor-infiltrating CD8+ T cell immune function effects for collaborative anti-tumor photothermal immunotherapy for cervical cancer. | Nanoscale Adv | 2024 | https://conductscience.org/library/papers/38868823 | PubMed |
| 11 | 34951582 | 5-Fluorouracil-Impregnated PLGA Coated Gold Nanoparticles for Augmented Delivery to Lung Cancer: In Vitro Investigations. | Anticancer Agents Med Chem | 2022 | https://conductscience.org/library/papers/34951582 | PubMed |
| 12 | 38736196 | Superparamagnetic Iron Oxide-Erastin-Polyethylene Glycol Nanotherapeutic Platform: A Ferroptosis-Based Approach for the Integrated Diagnosis and Treatment of Nasopharyngeal Cancer. | Mol Pharm | 2024 | https://conductscience.org/library/papers/38736196 | PubMed |
| 13 | 34413632 | Transferrin-Decorated Protein-Lipid Hybrid Nanoparticle Efficiently Delivers Cisplatin and Docetaxel for Targeted Lung Cancer Treatment. | Drug Des Devel Ther | 2021 | https://conductscience.org/library/papers/34413632 | PubMed |
| 14 | 36958539 | Integration of miRNA's theranostic potential with nanotechnology: Promises and challenges for Parkinson's disease therapeutics. | Mech Ageing Dev | 2023 | https://conductscience.org/library/papers/36958539 | PubMed |
| 15 | 39188876 | Impact of pulmonary rehabilitation on exercise capacity, health-related quality of life, and cardiopulmonary function in lung surgery patients: a retrospective propensity score-matched analysis. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39188876 | PubMed |
| 16 | 36935493 | Theranostic applications of selenium nanomedicines against lung cancer. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/36935493 | PubMed |
| 17 | 32739773 | SiO2-coated magnetic nano-Fe3O4 photosensitizer for synergistic tumour-targeted chemo-photothermal therapy. | Colloids Surf B Biointerfaces | 2020 | https://conductscience.org/library/papers/32739773 | PubMed |
| 18 | 36929005 | NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation. | Protein Cell | 2023 | https://conductscience.org/library/papers/36929005 | PubMed |
| 19 | 39115137 | Coordination-Driven Nanomedicine Mitigates One-Lung Ventilation-Induced Lung Injury via Radicals Scavenging and Cell Pyroptosis Inhibition. | Small | 2024 | https://conductscience.org/library/papers/39115137 | PubMed |
| 20 | 34779955 | Correction to: Piperine-Loaded Glycyrrhizic Acid- and PLGA-Based Nanoparticles Modified with Transferrin for Antitumor. | AAPS PharmSciTech | 2021 | https://conductscience.org/library/papers/34779955 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41551607 | Tumor-targeted multifunctional extracellular vesicles as drug carriers for lung cancer therapy. | Extracell Vesicles Circ Nucl Acids | 2025 | https://conductscience.org/library/papers/41551607 | PubMed |
| 41146652 | Advances in Targeted Engineered Nanoparticle-Based Therapeutics for Respiratory Diseases: Current Insights and Future Perspectives. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41146652 | PubMed |
| 41113763 | Engineered nanocarriers for targeted lung cancer therapy: mechanistic innovations and recent clinical progress. | Explor Target Antitumor Ther | 2025 | https://conductscience.org/library/papers/41113763 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| TFRC | 7037 | PubTator's text mining | https://conductscience.org/library/genes/7037 | NCBI Gene |
| YAP1 | 10413 | PubTator's text mining | https://conductscience.org/library/genes/10413 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39604129
GET https://conductscience.org/api/papers/v1/39604129/references?page=2